Neuromedical Systems, Inc.

With finance and M&A options drying up, smaller diagnostics companies are more squeezed than ever. Against the odds, a plucky few have snared good deals. Here's how. By Wendy Diller At a recent meetin

Neuromedical Systems Inc. 's bankruptcy filing in March is a cautionary tale of what can go wrong with young, seemingly "hot" medical device companies. Only a few years ago, NSI was at the forefront

The public markets have been cruel to small diagnostics companies, and that includes those involved in the once hot area of new cytology technologies. Witness the troubles of Neuromedical Systems Inc

The smoke from the Pap wars is beginning to clear. Of the three companies with FDA-cleared approaches to cervical cancer screening, Cytyc Corp. 's gamble seems to be paying off best. NeoPath Inc.